Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adolescent growth hormone continuation versus discontinuation after retesting of persistent GH deficiency
RBR-29sg4xgPhase 2Completed
- Sponsor
- Universidade de São Paulo
- Start
- May 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of somatropin in growth hormone deficiency (GHD) (3 arms), sponsored by Universidade de São Paulo. Started May 2017; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on RBR-29sg4xg.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-29sg4xg.